ADHD Genomic
ADHD Genomic
ADHD Genomic examines genetic factors that may influence attention, executive function, and neurotransmitter balance. It also includes pharmacogenomic context relevant to common ADHD medications. Use these insights with your clinician to guide more tailored strategies. Results appear in the Boomerang Kits App when ready.
This panel analyzes genetic variants affecting dopamine regulation and attention (DRD4, DAT1/SLC6A3), executive function and impulse control, and ADHD medication metabolism (CYP2D6, CYP2C19 pharmacogenomic markers).
DRD4 and DAT1 variants are among the most studied genetic contributors to ADHD — they affect how efficiently dopamine is produced, released, and cleared at synapses. CYP2D6 and CYP2C19 determine how your body metabolizes stimulant and non-stimulant ADHD medications, helping explain why the same dose works differently in different people.
This panel offers a deeper look at the genetic factors contributing to attention, hyperactivity, and executive function. By understanding how your genes affect neurotransmitter balance and medication response, you and your provider can make more informed choices in managing focus and optimizing cognitive health.
Attention regulation
DRD4 & DAT1 variants
Impulse control
Inhibitory response
Stimulant response
CYP2D6, CYP2C19 — PGx
Clinician-ready
Medication & behavioral guidance
- You have been diagnosed with ADHD and want to understand the genetic factors involved (Faraone SV et al., Nat Rev Dis Primers 2021 — ADHD heritability is estimated at 74%; DRD4 and DAT1 are among the most replicated risk genes.)
- You are considering ADHD medication and want to know how your genes may affect your response to stimulants or non-stimulants (CPIC Guidelines 2019 — CYP2D6 genotype is clinically actionable for atomoxetine dosing; CYP2C19 affects several non-stimulant ADHD medications.)
- You experience difficulty with focus, attention, impulse control, or executive function (APA DSM-5 — inattention and impulsivity are core diagnostic criteria for ADHD with documented neurobiological and genetic underpinnings.)
- You have tried multiple ADHD medications with inconsistent results (Relling MV & Evans WE, Nature 2015 — CYP2D6 poor and ultra-rapid metabolizer phenotypes explain non-response or toxicity in a significant subset of ADHD patients.)
- You have a child diagnosed with ADHD and want to understand your own genetic profile (Faraone SV et al., 2021 — first-degree relatives of ADHD patients have a 5–10x elevated risk; parental genotyping informs both familial risk and treatment planning.)
- Your provider has recommended pharmacogenomic testing before adjusting your ADHD medication (CPIC — pre-emptive CYP2D6/CYP2C19 testing is recommended before prescribing atomoxetine, guanfacine, and clonidine.)
Key Benefits
ADHD Genomic · Genetic & PGx Analysis · Cheek Swab Collection
Frequently Asked Questions
What's included, how to collect, when you'll see results, and how to use them.
What does this panel measure?
Genetic variants linked to dopamine regulation, focus, and executive function—including COMT, DRD4, and DAT1—plus pharmacogenomic markers that influence ADHD medication response.
How is this different from traditional testing?
The ADHD Genomic Panel applies precision pharmacogenomic analysis to uncover how your genetics may influence attention, focus, and cognitive balance, enabling informed decisions on treatment and lifestyle strategies.
Who benefits most from this panel?
Individuals managing focus challenges or clinicians exploring pharmacogenomic guidance for ADHD medication response.
How should I use these results?
Share your ADHD Genomic findings with your clinician to explore individualized care options.
Is this a diagnostic test?
No. This test provides insight into genetic markers and predispositions influencing attention and focus. Results are for informational purposes only.
How do I collect the sample?
Use the included sterile cheek swab, follow instructions carefully, place the swab into the transport tube, and mail it back using the prepaid envelope.
How do I return my sample?
Use the prepaid mailer provided in your kit and return your sample the same day of collection.
What if my sample can't be processed?
You'll be notified and sent a replacement kit at no cost.
How long until I see my results?
Results are typically available within 24–48 hours after our lab receives your sample.
Where do I view my results?
Log in to your secure Boomerang Kits App account to view your report.
Is my data private?
Your data is protected under HIPAA guidelines with strong encryption and administrative safeguards. Your results are accessible only to you unless you choose to share them.
Is this covered by insurance?
Boomerang Kits are not billed to insurance, though HSA/FSA options may apply.
What other panels complement this one?
GenomeRx Insight and Mental Health Genomic Panels for broader context in focus, mood, and medication response.
What does this panel measure?
Genetic variants linked to dopamine regulation, focus, and executive function—including COMT, DRD4, and DAT1—plus pharmacogenomic markers that influence ADHD medication response.
How is this different from traditional testing?
The ADHD Genomic Panel applies precision pharmacogenomic analysis to uncover how your genetics may influence attention, focus, and cognitive balance, enabling informed decisions on treatment and lifestyle strategies.
Who benefits most from this panel?
Individuals managing focus challenges or clinicians exploring pharmacogenomic guidance for ADHD medication response.
How should I use these results?
Share your ADHD Genomic findings with your clinician to explore individualized care options.
Is this a diagnostic test?
No. This test provides insight into genetic markers and predispositions influencing attention and focus. Results are for informational purposes only.
How do I collect the sample?
Use the included sterile cheek swab, follow instructions carefully, place the swab into the transport tube, and mail it back using the prepaid envelope.
How do I return my sample?
Use the prepaid mailer provided in your kit and return your sample the same day of collection.
What if my sample can't be processed?
You'll be notified and sent a replacement kit at no cost.
How long until I see my results?
Results are typically available within 24–48 hours after our lab receives your sample.
Where do I view my results?
Log in to your secure Boomerang Kits App account to view your report.
Is my data private?
Your data is protected under HIPAA guidelines with strong encryption and administrative safeguards. Your results are accessible only to you unless you choose to share them.
Is this covered by insurance?
Boomerang Kits are not billed to insurance, though HSA/FSA options may apply.
What other panels complement this one?
GenomeRx Insight and Mental Health Genomic Panels for broader context in focus, mood, and medication response.
